GENETIC POLYMORPHISMS OF CYP11B2 GENE IN HYPERTENSION

S MAZHAR; A WAJID; U FIRDOUS

doi:10.54112/bcsrj.v2024i1.1474

Authors

S MAZHAR Virtual University of Lahore, Pakistan
A WAJID Department of Biotechnology, Virtual University of Lahore, Pakistan
U FIRDOUS Department of Nursing, Saida Waheed College of Nursing FMH Lahore, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1474

Keywords:

Hypertension, CYP11B2, polymorphism, PCR-RFLP, case, control

Abstract

Hypertension is a complex, multifactorial disease influenced by both genetic and environmental factors. Essential hypertension is partially hereditary, with alterations in aldosterone synthesis and regulation potentially playing a role. Low-renin hypertension, characterized by an elevated ratio of aldosterone to plasma renin activity, is associated with inappropriate aldosterone biosynthesis. The cytochrome P450 family 11 subfamily B member 2 (CYP11B2) gene, which encodes aldosterone synthase, has been suggested as a possible candidate in the genetic predisposition to hypertension. Objective: This study aimed to investigate the association between the CYP11B2 gene polymorphism −344T/C (HaeIII) and hypertension by analyzing the allelic frequency and genotype distribution in hypertensive patients and healthy controls. Methods: A total of 65 hypertensive cases and 42 controls (including both males and females) were enrolled. Genomic DNA was extracted, and the CYP11B2 −344T/C polymorphism was analyzed using PCR-RFLP (Polymerase Chain Reaction-Restriction Fragment Length Polymorphism). The allelic frequency and the distribution of TT, TC, and CC genotypes in both cases and controls were examined. Results: The analysis revealed that the control group exhibited a higher frequency of the TT genotype, while the patient group displayed an increased prevalence of both CT and CC genotypes. Notably, the C allele was not observed in the control samples but was present at a significantly higher frequency in hypertensive patients. Statistical analysis indicated that the C allele was a significant risk factor for hypertension (p < 0.01).Conclusion: Our findings suggest that the CYP11B2 −344T/C polymorphism may contribute to the genetic predisposition to hypertension, particularly in individuals with a family history of the disease. These results highlight the importance of genetic factors in hypertension susceptibility and underscore the need for follow-up studies to assess the long-term risk and incidence of hypertension in individuals carrying genetic risk factors.

Downloads

Download data is not yet available.

References

Abdul AA., Aziz, Salo, Ameer, Abdul, genetic polymorphism of cyp11b2 in HBR Iraqi patients, World journal of Pharmacy and pharmaceutical sciences, 2015.

TomaschitzA, S Pilz, E Ritz, Ba Obermayer-Pietsch and TR Pieber. Aldosterone and Aterial Hypertension, Nat. Rev. Endocrinol, 2010; Vol 6, 83-93.

Anna F. Dominiczak, Domingo C. Negrin, James S. Clark, M. Julia Brosnan, Martin W. McBride, and M. Yvonne Alexander,Gene Mapping in Experimental Models to Vascular Gene Transfer Strategies, Hypertension, 2000;35:164–172

Aysha Almas, SaniyaSirajGodil , SaimaLalani , Zahra Aziz Samani and AamirHameed Khan, Good knowledge about hypertension is linked to better control of hypertension; A multicentre cross sectional study in Karachi, Pakistan. BMC Research Notes 2012.

Brand, E Chatelain, N. Mulatero, P. Fery, I.Curnow, k.Jeunemaitre, X. Corvol, P. Pascoe, L. and Soubrier, F. Structural analysis and evaluation of the aldosterone synthase gene inHypertension., 1998; 32: 198-204.

Colin D. Clyne, Yin Zhang, LiliyaSlutsker, J. Michael Mathis, Perrin C. White,William E. Rainey,Angiotensin II and Potassium Regulate Human CYP11B2 Transcription through Common cis-Elements: Molecular Endocrinology, Volume 11, Issue 5, 1 May 1997, Pages 638–649,

DonglanZohng, Guiging Wang, HeesooJoo, A Systematic review of Economic Evidence On Community Hypertension Interventions, Am J Prev Med 2017;53(6S2):S121–S130

Eleanor Davies,Christine D. Holloway, Mary C. Ingram, Gordon C. Inglis, Elaine C. Friel, Caroline Morrison ,Niall H. Anderson and John M. C. Connell, Aldosterone Excretion Rate and Blood Pressure in Essential Hypertension Are Related to Polymorphic Differences in the Aldosterone Synthase Gene CYP11B2, Hypertension 1999;33:703–707

Eva Brand, Nathalie Chatelain, Paolo Mulatero, Isabelle Féry, Kathleen Curnow, Xavier Jeunemaitre

Saleem F, MA Hassali, AA Shafie , S Bashir and M Atif, Perceptions of Disease State Management Among Pakistani Hypertensive Patients: Findings from a Focus Group Discussion, Tropical Journal of Pharmaceutical Research December 2011; 10 (6): 833-840

Holt TA, Thoro good M, Griffiths F, et al. Automated electronic reminders to facilitate primary cardiovascular disease prevention: randomised controlled trial. Br J Gen Pract 2010; 60(573): 251–256

TsukadaK, T Ishimitsu, M Teranishi, M Saitoh, M Yoshii, H Inada, S Ohta, M Akashi, J Minami, H Ono, M Ohrui &H Matsuoka, Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension, Journal of Human Hypertension 2002; volume 16, pages789–793

Kumar,NN. Benjafield, AV,Lin ,RC.,Wang, WY.Stowasser, M. and Morris, BJ Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension. J. Hypertension., 2003; 21: 1331-1337.

Lisa Kurland, HåkanMelhus, Julia Karlsson, Thomas Kahan, Karin Malmqvist,PeterÖhman, Fredrik Nyström, Anders Hägg, Lars Lind, Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: Results from the swedishirbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) trial ,American Journal of Hypertension, Volume 15, Issue 5, May 2002, Pages 389–393.

TaniraMOM and K a Al Balushi, Genetic variations related to hypertension: a review, Journal of Human Hypertension, 2005, volume 19, pages7–19

Naoharu Iwai, Hitoshi Shimoike, Nobuyuki Ohmichiand Masahiko Kinoshita,Angiotensinogen Gene and Blood Pressure in the Japanese Population:Hypertension: Vol 25,688-693

Setyawati I, Sunarti, Hastuti.P, Aldosteron levels and -344T/C aldosterone synthase in individuals with a family history of Hypertension, Bangladesh Journel of Medical Sciences, vol.15, No.3 July’16 Page : 435-440

TamakiS,NaoharuIwaiYasuyukiTsujita ,Genetic Polymorphism of CYP11B2 Gene and Hypertension in Japanese

NiuS, Bin Zhang, Keyong Zhang, Pengcheng Zhu, Jingping Li, Yujing Sun, Ning He, Mingtao Zhang, ZhiyingGao, Xueyan Li, AmutiSimayi, JieGe, Mingyu Cong, Wenna Zhou, and Changchun Qiu, Synergistic effects of gene polymorphisms of the renin–angiotensin–aldosterone system on essential hypertension in Kazakhs in Xinjiang, ClinExpHypertens, 2016; 38(1): 63–70.

ChandraS,DamanSalujaa,KamnaSrivastava, Atrial natriuretic peptide and aldosterone synthase gene in essential hypertension: A case–control study, Elsevier Volume 567, Issue 1, 1 August 2015, Pages 92-97

NawazSKF, SHasnain: NOISE INDUCED HYPERTENSION AND PREHYPERTENSION IN PAKISTAN, BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES 2010; 10 (3): 244-244

UppuluriMohanaVamsiet,NagalingamSwapna,GundaPadma,SattiVishnupriya &Tirunilai Padma Association of −344/T/C aldosterone synthase polymorphism (CYP11B2) with left ventricular structure and humoral parameters in young normotensive men: Blood Pressure: Vol 13, No.3).

HLUBOCKÁZ., M. JÁCHYMOVÁ, S. HELLER, V. UMNEROVÁ, V. DANZIG, V. LÁNSKÁ, K. HORKÝ, A. LINHART1, Association of the -344T/C Aldosterone Synthase Gene Variant with Essential Hypertension ,2009;Physiol. Res. 58: 785-792.

Tsujita Y et al. Lack of association between genetic polymorphism of CYP11B2 and hypertension in Japanese: the Suita Study. Hypertens Res 2001; 24: 105–109.

Kato N et al. Comprehensive analysis of the renin– angiotensin gene polymorphisms with relation to hypertension in the Japanese. J Hypertens 2000; 18: 1025–1032.

Pojoga L et al. Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens 1998; 11: 856–860?

Brand E et al. Aldosterone synthase gene (CYP11B2) C-344T polymorphism in Caucasians from the Berlin Salt-Sensitivity Trial (BeSST). J Hypertens 1999; 17: 1563–1567.

Davies E et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension 1999; 33: 703–707.

Tang W, Wu H, Zhou X, Cheby B, Dong Y, He L, Haijin Y, Xu L, Lu J, Li K, Xiao C, Association of the C-344T polymorphism of CYP11B2 gene with essential hypertension in Hani and Yi minorities of China. Clin Chim Acta. 2006, 364: 222-5.

Ikeda K, Isaka T, Fujioka K, Manome Y, Tojo K, Supression of aldosterone synthesis and secretion by Ca2+ channel antagonists. Int J Endocrinol. 2012:Article ID 519467, 6 pages.